跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,619 条关于
“Eikon Therapeutics”
全部
16,619
临床试验
3,570
药物
3,119
机构
1,123
资讯
8,807
上个月
Eikon Therapeutics Appoints CP Chang as Chief Scientific Officer to Advance Oncology Pipeline
11个月前
Eikon Therapeutics to Present Phase 2 Data on Novel TLR7/8 Co-Agonist EIK1001 for Advanced NSCLC at ESMO 2025
8个月前
Eikon Therapeutics Files for $100 Million IPO to Advance Late-Stage Cancer Pipeline
去年
Eikon Therapeutics Secures $351M Series D Funding to Advance Melanoma Treatment to Phase III
6个月前
Generate Biomedicines Targets $2.2 Billion Valuation in IPO as AI Drug Discovery Platform Advances Severe Asthma Therapy
去年
Pharma VC Investments Reach $6.5 Billion in Q1 2025 with Oncology Leading the Pack
上个月
IMPACT Therapeutics Licenses PARP Inhibitor Senaparib to Pharmanovia in Deal Worth Up to €423.5 Million
8个月前
Agomab and SpyGlass Raise Combined $350M in Biotech IPOs, Signaling Market Recovery
9天前
1cBio Licenses Preclinical PARP1 Inhibitor OC-3 to Lee's Pharm for Greater China and Southeast Asia in Deal Worth Up to $27 Million
昨天
CHMP Backs Senaparib as First-Line Maintenance Therapy in Advanced Ovarian Cancer
第 1 页,共 881 页
上一页
下一页